Radcliffe Capital Management, L.P. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 48 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$13,943
-50.0%
200,0490.0%0.00%0.0%
Q2 2023$27,877
+63.9%
200,0490.0%0.00%
+100.0%
Q1 2023$17,004
-99.2%
200,0490.0%0.00%
-98.5%
Q4 2022$2,052,503
+2.3%
200,0490.0%0.06%
+35.4%
Q3 2022$2,007,000
+0.2%
200,0490.0%0.05%
+4.3%
Q2 2022$2,003,000
+1.4%
200,0490.0%0.05%
+2.2%
Q1 2022$1,976,000200,0490.04%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 369,289$3,774,1340.21%
Radcliffe Capital Management, L.P. 200,049$2,052,5030.06%
LMR Partners LLP 125,000$1,277,5000.02%
Q Global Advisors, LLC 195,489$200.01%
MARSHALL WACE, LLP 190,150$1,954,7430.00%
MMCAP International Inc. SPC 325,000$32,4680.00%
PERISCOPE CAPITAL INC. 867,072$37,1400.00%
COWEN AND COMPANY, LLC 177,845$17,7660.00%
CANTOR FITZGERALD, L. P. 250,000$250.00%
EHP Funds Inc. 125,186$60.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders